Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some problems and pitfalls in developing countries.

J M K Murthy1

  • 1Department of Neurology, The Institute of Neurological Sciences, CARE Hospital, Nampally, Hyderabad, India. drjmk@sol.net.in

Epilepsia
|February 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Conventional and Ultrasound-assisted Femoral Nerve Motor Conduction Study in Healthy Controls.

Journal of medical ultrasound·2025
Same author

School Children with Epilepsy: A Need for Telehealth Enabled Epilepsy Smart School Program.

Indian journal of pediatrics·2024
Same author

Idiopathic pulmonary vein thrombosis: an under-recognised source of embolic stroke.

Practical neurology·2024
Same author

Spinocerebellar ataxia subtype 40: Report of a case and review of literature.

Parkinsonism & related disorders·2024
Same author

Autosomal Dominant Spinocerebellar Ataxias: The Subtypes.

Neurology India·2020
Same author

Myasthenia Gravis: Do the Subtypes Matter?

Annals of Indian Academy of Neurology·2020
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
Same journal

Outcome trajectories after pediatric epilepsy surgery vary by biopsychosocial phenotypes.

Epilepsia·2026
Same journal

Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Epilepsia·2026
Same journal

Long-term mortality after status epilepticus: A 5-year analysis study.

Epilepsia·2026
Same journal

The Epilepsy-Cog study: Methods to establish a harmonized study of late onset epilepsy in a metacohort of six population-based cohorts in the United States.

Epilepsia·2026
Same journal

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
See all related articles

Patients with epilepsy in developing countries face treatment barriers due to cost and cultural factors. Selecting affordable antiepileptic drugs (AEDs) is crucial, balancing efficacy and tolerability with individual patient affordability.

Area of Science:

  • Neurology
  • Global Health
  • Pharmacoeconomics

Background:

  • Epilepsy care in developed nations is evidence-based, contrasting with challenges in developing countries.
  • Patients in developing regions face significant barriers to adequate epilepsy treatment.
  • Care is often influenced by diverse local ethnic, racial, religious, economic, educational, and cultural factors.

Purpose of the Study:

  • To highlight the barriers to epilepsy care in developing countries.
  • To emphasize the role of cost in antiepileptic drug (AED) selection.
  • To advocate for tailored AED selection based on individual affordability.

Main Methods:

  • Review of factors influencing epilepsy treatment in developing countries.
  • Analysis of cost as a determinant in AED selection.

Related Experiment Videos

  • Discussion of balancing efficacy, tolerability, and cost for individual patients.

    • Main Results:

    • Cost is a primary factor influencing AED choice in resource-limited settings.
    • Traditional, less expensive AEDs are often recommended as first-line therapy.
    • Individualized treatment plans are necessary, considering patient affordability.

    Conclusions:

    • Epilepsy management in developing countries requires careful consideration of economic and cultural contexts.
    • Affordable and effective antiepileptic drug selection is paramount.
    • Tailoring treatment to individual patient affordability ensures better outcomes.